27 related articles for article (PubMed ID: 19261478)
1. Incorporation of 2,3-diaminopropionic acid into linear cationic amphipathic peptides produces pH-sensitive vectors.
Lan Y; Langlet-Bertin B; Abbate V; Vermeer LS; Kong X; Sullivan KE; Leborgne C; Scherman D; Hider RC; Drake AF; Bansal SS; Kichler A; Mason AJ
Chembiochem; 2010 Jun; 11(9):1266-72. PubMed ID: 20480482
[TBL] [Abstract][Full Text] [Related]
2. Polymers of functionalized diaminopropionic acid are efficient mediators of active exogenous enzyme delivery into cells.
Romanowska A; Rachubik P; Piwkowska A; Wysocka M
Sci Rep; 2024 Jun; 14(1):13185. PubMed ID: 38851838
[TBL] [Abstract][Full Text] [Related]
3. Targeting Reactive Carbonyl Species with Natural Sequestering Agents.
Hwang SW; Lee YM; Aldini G; Yeum KJ
Molecules; 2016 Feb; 21(3):280. PubMed ID: 26927058
[TBL] [Abstract][Full Text] [Related]
4. New 2,3-diaminopropionic acid inhibitors of AGE and ALE formation.
Audic N; Potier G; Sasaki NA
Org Biomol Chem; 2013 Feb; 11(5):773-80. PubMed ID: 23242031
[TBL] [Abstract][Full Text] [Related]
5. Aged garlic extract and S-allyl cysteine prevent formation of advanced glycation endproducts.
Ahmad MS; Pischetsrieder M; Ahmed N
Eur J Pharmacol; 2007 Apr; 561(1-3):32-8. PubMed ID: 17321518
[TBL] [Abstract][Full Text] [Related]
6. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
Kiho T; Kato M; Usui S; Hirano K
Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal pyrazinones: a new class of peptide-bound advanced glycation end-products.
Krause R; Kühn J; Penndorf I; Knoll K; Henle T
Amino Acids; 2004 Aug; 27(1):9-18. PubMed ID: 15309567
[TBL] [Abstract][Full Text] [Related]
8. Methylglyoxal: its presence and potential scavengers.
Tan D; Wang Y; Lo CY; Ho CT
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():261-4. PubMed ID: 18296351
[TBL] [Abstract][Full Text] [Related]
9. N-Terminal 2,3-diaminopropionic acid (Dap) peptides as efficient methylglyoxal scavengers to inhibit advanced glycation endproduct (AGE) formation.
Sasaki NA; Garcia-Alvarez MC; Wang Q; Ermolenko L; Franck G; Nhiri N; Martin MT; Audic N; Potier P
Bioorg Med Chem; 2009 Mar; 17(6):2310-20. PubMed ID: 19261478
[TBL] [Abstract][Full Text] [Related]
10. Methylglyoxal in food and living organisms.
Nemet I; Varga-Defterdarović L; Turk Z
Mol Nutr Food Res; 2006 Dec; 50(12):1105-17. PubMed ID: 17103372
[TBL] [Abstract][Full Text] [Related]
11. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
Khalifah RG; Chen Y; Wassenberg JJ
Ann N Y Acad Sci; 2005 Jun; 1043():793-806. PubMed ID: 16037307
[TBL] [Abstract][Full Text] [Related]
12. Modulation of insulin action by advanced glycation endproducts: a new player in the field.
Schalkwijk CG; Brouwers O; Stehouwer CD
Horm Metab Res; 2008 Sep; 40(9):614-9. PubMed ID: 18792872
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
